Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.

These preliminary results suggest that pioglitazone treatment for non-obese PCOS women of reproductive age may be effective to help the resumption of the menstrual cycle, and the patients showed a different response pattern according to their baseline free testosterone levels.